Corcept Therapeutics reported $98.82M in Sales Revenues for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Aurora Cannabis Inc ACB:CN 60.59M 478K
Canopy Growth Corp WEED:CN C$ 140.97M 9.6M
Corcept Therapeutics CORT:US $ 98.82M 2.69M
Depomed DEPO:US $ 25.47M 0.1M
Eleven Biotherapeutics EBIO:US $ 0M 40M
Lexicon Pharmaceuticals LXRX:US $ 0.04M 0.02M
Nektar Therapeutics NKTR:US $ 25.01M 0.09M
Novartis NOVN:VX SF 13522M 155M
Tg Therapeutics TGTX:US $ 2.32M 0.29M